VPS34 inhibition decreases intracellular levels of cholesteryl-esters, blocks cholesterol uptake and enhances lysosomal degradation of LDLR. by Marek J. Kobylarz (9292599)

OP50 <i>E. coli</i>-fed nematodes are generally healthy while pathogen-fed worms demonstrate a decrease in overall health. by Michelle R. Bond (669241)

“…(B) The average pumping rate for nematodes fed <i>P. aeruginosa</i> is decreased when compared to N2 animals fed OP50. Worms with a <i>pmk-1(km25)</i> background exhibit the largest decrease in pumping rate. …”

Decrease in GABA_B expression in APP mice. by Ksenia V. Kastanenka (3692380)

cAMP and PKA/AKAP1 decrease mobility and promote mitochondrial translocation of Drp1. by Ronald A. Merrill (224222)

Ageing results in an abrupt decrease in overall neurogenesis in the mouse DG. by Joana Gil-Mohapel (462002)

“…Arrow in (E) indicates a BrdU/NeuN double-labeled cell in the DG of a 9 month-old mouse. …”

Damsin (D) and ambrosin (A) treatment decreases the CSC population. by Wendy Soria Sotillo (4408105)

<i>roh</i> mutation results in Rh1 decrease. by Yu Huang (15093)

“…Scale bar, 50 μm. (B) Western blotting showing decreased Rh1 levels in the <i>roh</i>^{<i>EY04039</i>} mutant (<i>ey-flp Rh1</i>::<i>GFP; FRT42D roh</i>^{<i>EY04039</i>}<i>/ FRT42D GMR-hid CL</i>); the INAD and TRP levels are not affected compared to the wild-type. …”

TR4 and TR9 decrease hepatoma cell viability at a lower TC50 than Sorafenib, SAHA or 5-Fluorouracil. by Nicole Lange (335740)

Expression of Egln3 decreases tumor aggression, increases survival and normalizes glioma vascular architecture. by Vicki A. Sciorra (312082)

Glutamate excitotoxicity decreases viability of cultured hippocampal GABAergic neurons. by Márcio S. Baptista (365618)

Viability of microencapsulated FP ICCs decreased with time post-transplantation. by Vijayaganapathy Vaithilingam (390354)

“…<p>A) Fluorescent images of encapsulated FP ICCs stained with 6-CFDA for viable cells (green) and PI for non-viable cells (red) to assess viability at (A) pre-transplantation, (B) day 1, (C) day 3, (D) day 7, (E) day 14 and (F) day 21 post-transplantation. …”

Capzb2 coimmunoprecipitates with βIII-tubulin in brain lysates and decreases tubulin polymerization in vitro. by David A. Davis (239142)

“…(E) Capzb2 decreases the rate and the extent of tubulin polymerization in a concentration-dependent manner. …”

Loss of HER3 expression decreases the sensitivity to elisidepsin treatment. by Cristina Teixidó (105298)

Knockout or inhibition of CCR1 decreases peritoneal inflammation and CAIA. by Nuruddeen D. Lewis (192385)

The rate of lariat formation is decreased two-fold by isoginkgetin treatment. by Jesse M. Gray (527662)

“…(<b>C</b>) Isoginkgetin treatment leads to a decreased rate of lariat formation (* indicates <i>p</i> = 0.02) without affecting exon ligation or excised lariat degradation (<i>p</i> = 0.22, 0.08), with calculations as in <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0089673#pone-0089673-g001" target="_blank">Fig. 1</a>. …”

mTOR activity is decreased in KSR1-deficient T cells. by Marie Le Borgne (337225)

Decreased DG GCL volume of postnatal CRAF ko mice. by Verena Pfeiffer (158248)

Zinc exposure decreases NR1 clusters and NMDA currents. by Jia Zhu (135506)

“…Scale bar, 50 µm. (B) and (C) show the quantification of (A). …”

Adenosine inhibits AMPA EPSCs by decreasing presynaptic glutamate release. by Shouping Wang (402959)

WT∶MU ratio is decreased in differentiated hOE-MSCs. by Nathalie Boone (234904)